Trevor Bezdek Buys Shares of GoodRx Holdings, Inc.
Trevor Bezdek recently acquired 73,434 shares of GoodRx Holdings, Inc.
Key Points
- Trevor Bezdek bought 73,434 shares of GoodRx Holdings, Inc. on June 16, 2026.
- GoodRx trades near $2.73 per share with a market cap of $924.6 million.
- Analysts maintain a hold rating with a target mean price of $3.18.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 16, 2026, Trevor Bezdek purchased 73,434 shares of GoodRx Holdings, Inc. (NasdaqGS: GDRX). This insider transaction did not specify a purchase price or total value, but it marks a significant acquisition of shares.
Other Institutional Activity in GoodRx Holdings
Several institutional investors have recently adjusted their positions in GoodRx Holdings. LSV Asset Management increased its holdings by 2,156,031 shares, ending with 4,981,931 shares valued at approximately $9.77 million. Ameriprise Financial Inc. also boosted its stake by 1,183,329 shares, totaling 4,455,760 shares worth about $8.73 million. Meanwhile, Vanguard Portfolio Management LLC initiated a new position with 3,362,864 shares valued at $6.59 million.
GoodRx Holdings, Inc. Stock Down 26.1%
Shares of GoodRx Holdings, Inc. are trading near $2.73. The company has a market capitalization of approximately $924.6 million and a P/E ratio of 45.5, with a forward P/E of 7.6. Its beta is 1.615, indicating some volatility. Over the past year, the stock has traded between $1.77 and $5.81. The 50-day moving average stands at $2.54, while the 200-day moving average is $2.89. GoodRx maintains a current ratio of 1.47 and a quick ratio of 0.56, with a debt-to-equity ratio of 87.04.
Recent Earnings
GoodRx Holdings reported revenue of $787.9 million with a slight revenue decline of 4.4%. The company achieved an earnings per share (EPS) of $0.06, a net margin of 2.61%, and a return on equity (ROE) of 3.22%. The next earnings report is scheduled for August 5, 2026.
Insider Buying and Selling at GoodRx Holdings, Inc.
Several insiders, including Trevor Bezdek, Douglas Joseph Hirsch, Kelly Kennedy, Ronald Bruehlman, Scott Wagner, and Agnes Rey-Giraud, each acquired 73,434 shares of GoodRx Holdings on June 16, 2026. These transactions were not part of a pre-planned trading program.
Analysts Set New Price Targets
On May 14, 2026, Citigroup maintained its buy rating for GoodRx with a price target of $4. Similarly, TD Cowen reiterated a buy rating with a $4 target on May 11, 2026. The consensus among analysts is a hold rating, with an average price target of $3.18 based on 13 opinions.
About GoodRx Holdings, Inc.
GoodRx Holdings, Inc. is a healthcare company based in Santa Monica, California. It operates a platform that helps consumers compare prices for prescription drugs and find savings. The company offers a range of services, including subscription programs, telehealth services through GoodRx Care, and solutions for pet medications. Founded in 2011, it supports pharmacy benefit managers in managing formularies and pricing.
Bottom Line
Trevor Bezdek's recent purchase of GoodRx shares highlights insider interest in the company. GoodRx continues to operate in the competitive healthcare sector, offering cost-saving tools for consumers. While the company's recent financial performance shows some challenges, analysts maintain a hold rating with a moderate price target. Investors should note that insider transactions provide a glimpse into potential confidence but are not definitive buy or sell signals.
Get GoodRx Holdings, Inc. alerts
New 13F filings, insider trades, and analyst moves on $GDRX, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.